In the past 90 days, Kuros Biosciences AG has recorded four insider trading transactions, resulting in a net value of approximately -1.64 million CHF, primarily driven by significant selling activity. Notably, two sales on April 23 and May 28 accounted for over 1.28 million CHF and 181,860 CHF, respectively, while two smaller purchases occurred on March 24 and June 17. The company's stock has increased by 37.3% over the same period, with the next earnings report scheduled for August 13, 2025.